Quoin Pharmaceuticals receives U.S. patent allowance for Netherton drug

Go back to Quoin Pharmaceuticals receives U.S. patent allowance for Netherton drug
(NASDAQ: QNRX) Delayed: 5.57 +0.58 (11.62%)
Previous Close $4.99    52 Week High
Open $5.29    52 Week Low
Day High $5.88    P/E N/A 
Day Low $5.02    EPS
Volume 72,107